P21
Typical Dosing Protocols (Research/Compounded Use Only) – P21
Common protocol: 1–2 mg subcutaneously once daily for 20–30 consecutive days, followed by an equal length break (20–30 days).
Other reported ranges: 0.5–3 mg daily; some users run 1 mg daily for 30 days then switch to maintenance of 1 mg 3–5 times per week. Cycles are typically repeated 2–3 times per year.
Reconstitution example (for a typical 10 mg vial): Add 2 mL bacteriostatic water (yielding ~5 mg/mL).
1 mg = 0.2 mL (20 units on U-100 insulin syringe)
2 mg = 0.4 mL (40 units)
Administration: Subcutaneous injection (abdomen or thigh), usually in the morning.
Dosing is highly individualized based on goals and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
